http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021076570-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78587acbfc8d4c9e9ac3baa7021087d7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
filingDate 2020-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_214f2a0fc40f1193f902360541d736df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2390dc11144fafe160724601700ae89e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80dcb48bf8667196b01f2711750d34c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ace4f939378b40cf5090535a0307b7b5
publicationDate 2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021076570-A3
titleOfInvention Chagas disease vaccine antigens with improved stability and decreased aggregation
abstract Provided herein are compositions and methods for the prevention and treatment of Chagas disease and acute and chronic symptoms thereof. The compositions comprise recombinant proteins based on an amino terminal fragment of the TSA-1 protein from Trypanosoma cruzi. In the fragment, one or more Cys residues is mutated to prevent the formation of disulfide bonds and to enhance solubility. The recombinant proteins also include a carboxyl terminal fragment of the TSA-1 protein from Trypanosoma cruzi to provide additional stability and solubility. The resulting recombinant protein remains soluble upon prolonged storage at low temperatures and elicits a robust immune response upon administration, including decreasing the number of inflammatory cells in heart tissue of subjects.
priorityDate 2019-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004067040-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017160849-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 20.